SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63389 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60943re: "the good old days" and the economy. My wife bought a house in therickerickson-7/10/2022
60942scitechdaily.comsysiphus-7/9/2022
60941I think the big variable for the stock market is whether the Fed can get controlstockdoc7717/9/2022
60940no comments on SGEN supposed takeover by Merck for $40bill..double IMMU and it wscorman1-7/7/2022
60939Bad news on CTMX. Their breast cancer trial results are in, and not good. I am sdrtom123437/7/2022
60938I am more optimistic. A few months ago I opined that biotechs would have a majostockdoc7727/6/2022
60937IMHO, the market is currently in no man’s land. By that I mean that it has enterOlecranon27/6/2022
60936SRPT results Sarepta Therapeutics’ Investigational Gene Therapy SRP-9001 for Duerickerickson27/6/2022
60935I'm gobsmacked over the XBI ride I've been taking over the past couple mweatherproof27/6/2022
60934Essentially none in France, a few in Austria and Germany, and close to zero in Ustockdoc77-7/5/2022
60933What percentage of the people you saw were wearing masks for Covid protection? Dsysiphus-7/5/2022
60932Was in Europe for two weeks just got back yesterday. I still believe that this stockdoc7727/5/2022
60931Yes, I am always gobsmacked when I see codswallop used.jargonweary27/2/2022
60930AUPH sale speculation: Not again ;) Speculation for a buyout was rife last falerickerickson-7/2/2022
60929Aurinia Pharmaceuticals gains on speculation of Otsuka interest Jul. 01, 2022 1Olecranon17/1/2022
60928"He has not seen the DSMB charter which is restricted to anyone on the fronghettogoulash-7/1/2022
60927Looking for something else, I just reviewed Joe Springer's interview with Drghettogoulash16/30/2022
60926I just reviewed the FDA's "Guidance for Clinical Trial Sponsors-- Estabghettogoulash16/30/2022
60925GG, I would have preferred if you didn’t work to dissuade the shorts until afterOlecranon-6/27/2022
60924Here are a few comments from that YMB thread: ---- Archisaurus: Cassava has a neghettogoulash16/27/2022
60923A month ago I posted a rather brash conjecture on the IV message board concerninghettogoulash16/27/2022
60922Question #9: When will we expect interim results for the Phase 3 program? Ansghettogoulash-6/26/2022
60921So Filamin A seems to be a factor in Alzheimer's pathology. Who knew?ghettogoulash-6/26/2022
60920The Alzheimer’s Cure Conundrum Millions of dollars later, scientists are still uFitzhughlaw86/26/2022
60919In Idahoranch’s neck of the woods… [graphic]erippetoe-6/25/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News